$3.17
0.186.02%
At close: -
$3.17
0.000.00%
After Hours: Apr 11, 4:00 PM EDT
Comments
Loading...
Voyager Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:VYGR | Benzinga
Voyager Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 12
EPS Estimate
$-0.440
Quarterly Revenue Estimate
$13.55M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$80.00M
Analyze the earnings history of Voyager Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VYGR | Voyager Therapeutics | -$0.20 | -$0.44 | — | — | $19.52M | $13.55M | — | — | 05/12/2025 | Get Alert |
| VYGR | Voyager Therapeutics | $1.25 | -$0.35 | -$0.59 | -68.57% | $90.06M | $16.58M | $6.28M | -62.14% | 03/11/2025 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.59 | -$0.45 | -$0.16 | 64.44% | $4.61M | $11.89M | $24.63M | 107.14% | 11/12/2024 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.51 | -$0.41 | -$0.18 | 56.10% | $4.85M | $9.46M | $29.58M | 212.66% | 08/06/2024 | Get Alert |
| VYGR | Voyager Therapeutics | $2.94 | -$0.44 | -$0.20 | 54.55% | $150.48M | $9.41M | $19.52M | 107.40% | 05/13/2024 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.61 | -$0.29 | $1.25 | 531.03% | -$1.55M | $20.63M | $90.06M | 336.55% | 02/28/2024 | Get Alert |
| VYGR | Voyager Therapeutics | $0.45 | -$0.58 | -$0.59 | -1.72% | $41.09M | $2.91M | $4.61M | 58.56% | 11/06/2023 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.50 | -$0.59 | -$0.51 | 13.56% | $712.00K | $2.00M | $4.85M | 142.65% | 08/03/2023 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.56 | $0.77 | $2.94 | 281.82% | $658.00K | $41.00M | $150.48M | 267.02% | 05/09/2023 | Get Alert |
| VYGR | Voyager Therapeutics | $0.15 | -$0.55 | -$0.61 | -10.91% | $28.07M | $4.19M | -$1.55M | -136.99% | 03/07/2023 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.67 | -$0.32 | $0.45 | 240.62% | $1.50M | $9.42M | $41.09M | 336.16% | 11/08/2022 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.80 | — | -$0.50 | — | $1.36M | — | $712.00K | — | 08/04/2022 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.58 | — | -$0.56 | — | $6.50M | — | $658.00K | — | 05/04/2022 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.43 | -$0.32 | $0.15 | 146.88% | $6.54M | $14.55M | $28.07M | 92.94% | 03/08/2022 | Get Alert |
| VYGR | Voyager Therapeutics | $2.27 | -$0.73 | -$0.67 | 8.22% | $117.84M | $2.14M | $1.50M | -29.91% | 11/02/2021 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.23 | -$0.67 | -$0.80 | -19.40% | $28.68M | $6.39M | $1.36M | -78.76% | 08/06/2021 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.66 | -$0.66 | -$0.58 | 12.12% | $18.07M | $6.99M | $6.50M | — | 05/10/2021 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.34 | -$0.56 | -$0.43 | 23.21% | $32.67M | $13.32M | $6.54M | -50.92% | 02/25/2021 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.41 | — | $2.27 | — | $20.43M | — | $117.84M | — | 11/09/2020 | Get Alert |
| VYGR | Voyager Therapeutics | $0.29 | -$0.72 | -$0.23 | 68.06% | $46.09M | $15.52M | $28.68M | 84.80% | 08/10/2020 | Get Alert |
| VYGR | Voyager Therapeutics | -$0.81 | — | -$0.66 | — | $5.20M | — | $18.07M | — | 05/06/2020 | Get Alert |
Voyager Therapeutics (VYGR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $-0.59 | $-0.35 | -68.6 % |
| Q3 | 2024-11-12 | $-0.16 | $-0.45 | 64.4 % |
| Q2 | 2024-08-06 | $-0.18 | $-0.41 | 56.1 % |
| Q1 | 2024-05-13 | $-0.20 | $-0.44 | 54.5 % |
Voyager Therapeutics (VYGR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-11 | $6.28M | $16.58M | -62.1 % |
| Q3 | 2024-11-12 | $24.63M | $11.89M | 107.1 % |
| Q2 | 2024-08-06 | $29.58M | $9.46M | 212.7 % |
| Q1 | 2024-05-13 | $19.52M | $9.41M | 107.4 % |
FAQ
When is Voyager Therapeutics (NASDAQ:VYGR) reporting earnings?
Voyager Therapeutics (VYGR) is scheduled to report earnings on May 12, 2025. The last reported earnings were for reported on March 11, 2025 for Q4.
What were the latest earnings per share (EPS) for Voyager Therapeutics (NASDAQ:VYGR)?
The Actual EPS was $-0.59, which missed the estimate of $-0.35.
What were Voyager Therapeutics’s (NASDAQ:VYGR) revenues?
The Actual Revenue was $6.3M, which missed the estimate of $16.6M.
Browse earnings estimates, EPS, and revenue on all stocks.